CHEM 125a - Lecture 30 - Esomeprazole as an Example of Drug Testing and Usage
Lecture 30 - Esomeprazole as an Example of Drug Testing and Usage
Overview
The chemical mode of action of omeprazole is expected to be insensitive to its stereochemistry, making clinical trials of the proposed virtues of a chiral switch crucial. Design of the clinical trials is discussed in the context of marketing. Otolaryngologist Dr. Dianne Duffey provides a clinician's perspective on the testing and marketing of pharmaceuticals, on the FDA approval process, on clinical trial system, on off-label uses, and on individual and institutional responsibility for evaluating pharmaceuticals.
Resources
Professor McBride's web resources for CHEM 125 (Fall 2008)
http://webspace.yale.edu/chem125_oyc/#L30
This website may include third-party materials pertaining to relevant topics, provided for the user's convenience. Yale does not control or take responsibility for the content of any off-site pages or linked sites.
Assignment
Reading assignments, problem sets, PowerPoint presentations, and other resources for this lecture can be accessed from Professor McBride's on-campus course website, which was developed for his Fall 2008 students. Please see Resources section below.
Lecture Chapters
- Introduction: The Chemical Properties and Reactivity of Prilosec [0]
- The Economics of Clinical Trials [418]
- Duffey: How Do I Know that the Drug is Effective? [1197]
- The Phases of Clinical Trials, Results for Esomeprazole and Omeprazole, and Off-Label Use [1826]
- Pharmaceutical Marketing Mentality and Q&A [2521]
Lecture Chapters
- Introduction: The Chemical Properties and Reactivity of Prilosec [0]
- The Economics of Clinical Trials [418]
- Duffey: How Do I Know that the Drug is Effective? [1197]
- The Phases of Clinical Trials, Results for Esomeprazole and Omeprazole, and Off-Label Use [1826]
- Pharmaceutical Marketing Mentality and Q&A [2521]